Tryptophan

Tryptophan

SCHEMBL28531880

N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O.O=C1C=CC(=O)C=C1

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.86
▸ KDM4E B2RXH2 3/20 0.86
▸ MAPT P10636 3/20 0.86
▸ LMNA P02545 2/20 0.86
▸ TSHR P16473 2/20 0.86
▸ BLM P54132 2/20 0.86
▸ PMP22 Q01453 2/20 0.86
▸ MEN1 O00255 2/20 0.86
▸ MPO P05164 1/20 0.86
▸ HIF1A Q16665 1/20 0.86
▸ SMN1; SMN2 Q16637 1/20 0.62
▸ APAF1 O14727 1/20 0.60
▸ POLB P06746 1/20 0.60
▸ RECQL P46063 1/20 0.60
▸ L3MBTL1 Q9Y468 1/20 0.60
▸ HTR2A P28223 3/20 0.60
▸ HTR1A P08908 2/20 0.60
▸ HTR2C P28335 2/20 0.60
▸ SLC6A4 P31645 2/20 0.60
▸ HTR7 P34969 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tryptophan SCHEMBL28523647 0.94 KMT2A (0.76) KMT2AKDM4EMAPTLMNATSHR
Dl-Tryptophan SCHEMBL19161120 0.93 KMT2A (1.00) KMT2AKDM4EMAPTLMNATSHR
Dl-Tryptophan SCHEMBL475349 0.93 KMT2A (1.00) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL4732053 0.93 KMT2A (1.00) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL289043 0.93 KMT2A (1.00) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL23141133 0.93 KMT2A (1.00) KMT2AKDM4EMAPTLMNATSHR
Dl-Tryptophan SCHEMBL7327 0.93 KMT2A (1.00) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL475350 0.93 KMT2A (1.00) KMT2AKDM4EMAPTLMNATSHR
Dl-Tryptophan SCHEMBL4732052 0.93 KMT2A (1.00) KMT2AKDM4EMAPTLMNATSHR
Dl-Tryptophan SCHEMBL289042 0.93 KMT2A (1.00) KMT2AKDM4EMAPTLMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118317944-A Acyclic lipids and methods of use thereof 雷纳嘉德医疗管理公司 2024-07-09 — — CN disclosed
CN-118234707-A Cyclic lipids and methods of use thereof 雷纳嘉德医疗管理公司 2024-06-21 — — CN disclosed
CN-117795054-A Reactor system and method of use thereof 全腾生物科技股份有限公司 2024-03-29 — — CN disclosed
CN-112442489-A Improved polypeptide for converting substrate 3-keto-deoxynivalenol into 3-epi-deoxynivalenol 爱尔伯股份公司 2021-03-05 — — CN disclosed
Send feedback